In 2017, more than 119,000 bloodstream staph infections occurred and 20,000 people died from them. What’s more, a rise in the infections could be due to rampant opioid use.
Category: Healthcare Finance News
Nearly all hospital leaders say supply chain optimization improves margins, survey shows
Supply chain management is a medium or high priority yet just 13 percent say it’s a top investment priority.
Nursing homes subject to one star rating if they go more than four days without an RN onsite
CMS is also establishing separate quality ratings for short-stay and long-stay residents.
Amazon, Berkshire, JPMorgan healthcare project gets its name: Haven
Atul Gawande says the company he’ll head wants to “change the way people experience health care so that it is simpler, better, and lower cost.”
New program at University of Maryland St. Joseph’s Medical Center shows effectiveness in curbing readmissions
Investing in social determinants of health holds the potential to provide ROI in the form of fewer readmissions-based penalties.
Pennsylvania hospitals test new funding model to help with ongoing struggles
The move is designed to help the facilities struggling with a declining number of patients and a shifting payer mix.
CMS wants to know how best to sell health insurance across state lines
The agency seeks information on removal of regulatory, operational and financial barriers, but will insurers step into the interstate market?
Planned Parenthood, American Medical Association, 22 states, D.C., sue HHS over Title X final rule
Gag order prevents Title X providers from telling pregnant patients how and where they can access abortion safely and legally, lawsuit says.
Four top health systems share unique approaches to improve patient engagement
These providers have created diverse models of care that incorporate use of patient-centered technologies with measurable outcomes.
Scott Gottlieb lauded for tough stance on tobacco and vaping, approval of new drugs at FDA
Policy experts and providers said his charge in the face of the tobacco industry and work to speed drug approvals has improved public health – but one group attacked his tenure, citing FDA’s decision on a powerful opioid.
